POTTI RAM

CIK 00014658241 companyLAURELTON, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001465824

Recent Transactions

50 trades

Disposition to Issuer
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-05-09$0.07/sh−391,500→ 15,235,392 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-04-29$0.04/sh−13,367,481→ 15,626,892 total
Disposition to Issuer
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-04-29$0.08/sh−140,000→ 24,538,536 total
Disposition to Issuer
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-04-29$0.08/sh−130,000→ 24,538,546 total
Conversion
ELITE PHARMACEUTICALS INC /NV/$ELTP
Series E Convertible Preferred Stock
2013-04-26$1000.00/sh−200→ 1,600 total
Conversion
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-04-26+8,230,453→ 24,668,546 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Warrants
2013-04-26+4,424,333→ 26,727,001 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-04-26$0.04/sh+4,455,827→ 9,399,712 total
Disposition to Issuer
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-04-26$0.08/sh−243,926→ 16,438,093 total
Disposition to Issuer
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-04-25$0.08/sh−150,000→ 16,682,019 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Warrants
2013-03-25+666,667→ 2,436,665 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Warrants
2013-03-25−6,666,667→ 2,436,665 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-03-25$0.04/sh−13,550,136→ 15,477,006 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-03-25$0.04/sh+1,355,014→ 15,060,666 total
Conversion
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-03-21+15,946,502→ 29,027,142 total
Conversion
ELITE PHARMACEUTICALS INC /NV/$ELTP
Series E Convertible Preferred Stock
2013-03-21$1000.00/sh−387.5→ 1,800 total
Award
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-03-07$0.08/sh+184,706→ 13,080,641 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-01-22$0.09/sh−356,700→ 12,895,935 total
Exercise/Conversion
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-01-14$0.06/sh+6,032,000→ 13,252,635 total
Exercise of In-Money
ELITE PHARMACEUTICALS INC /NV/$ELTP
Warrant
2013-01-14$0.06/sh−6,032,000→ 9,103,332 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2013-01-11$0.09/sh−2,339,000→ 7,220,635 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2012-12-26$0.09/sh−561,000→ 9,559,635 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2012-12-21$0.04/sh−17,005,400→ 10,120,655 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Warrants
2012-12-21−8,366,667→ 15,135,332 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2012-12-19$0.09/sh−243,300→ 27,126,055 total
Award
ELITE PHARMACEUTICALS INC /NV/$ELTP
Series E Convertible Preferred Stock
2012-09-10$1000.00/sh+250→ 2,187.5 total
Purchase
ELITE PHARMACEUTICALS INC /NV/$ELTP
Series E Convertible Preferred Stock
2012-06-29$1000.00/sh+187.5→ 1,937.5 total
Award
ELITE PHARMACEUTICALS INC /NV/$ELTP
Series E Convertible Preferred Stock
2012-06-29$1000.00/sh+187.5→ 1,937.5 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2012-05-04$0.04/sh−9,214,097→ 27,369,355 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Warrants
2012-05-02−4,533,334→ 23,501,999 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Warrant
2012-04-25+4,000,000→ 4,000,000 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Warrant
2012-04-20−11,964,667→ 28,035,333 total
Other
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2012-04-18−24,281,850→ 36,583,452 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2012-03-27$0.09/sh−735,000→ 60,865,302 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2012-03-26$0.09/sh−225,000→ 61,600,302 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2012-03-23$0.10/sh−1,765,000→ 61,825,302 total
Award
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2012-03-20$0.10/sh+231,633→ 63,590,302 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2012-03-16$0.10/sh−85,000→ 63,358,669 total
Purchase
ELITE PHARMACEUTICALS INC /NV/$ELTP
Series E Convertible Preferred Stock
2012-03-15$1000.00/sh+125→ 1,750 total
Award
ELITE PHARMACEUTICALS INC /NV/$ELTP
Series E Convertible Preferred Stock
2012-03-15$1000.00/sh+125→ 1,750 total
Conversion
ELITE PHARMACEUTICALS INC /NV/$ELTP
Series E Convertible Preferred Stock
2012-03-14$1000.00/sh−187.5→ 1,625 total
Conversion
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2012-03-14+7,621,951→ 63,443,669 total
Conversion
ELITE PHARMACEUTICALS INC /NV/$ELTP
Series E Convertible Preferred Stock
2012-02-21$1000.00/sh−1,300→ 1,812.5 total
Conversion
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2012-02-21+52,845,528→ 55,821,718 total
Sale
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2012-01-26$0.12/sh−407,949→ 2,976,190 total
Purchase
ELITE PHARMACEUTICALS INC /NV/$ELTP
Series E Convertible Preferred Stock
2011-08-12$1000.00/sh+125→ 3,112.5 total
Conversion
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2011-07-06+2,976,190→ 3,384,139 total
Conversion
ELITE PHARMACEUTICALS INC /NV/$ELTP
Series E Convertible Preferred Stock
2011-07-06$1000.00/sh−75→ 2,987.5 total
Conversion
ELITE PHARMACEUTICALS INC /NV/$ELTP
Common Stock
2011-06-06+2,976,190→ 3,384,139 total
Conversion
ELITE PHARMACEUTICALS INC /NV/$ELTP
Series E Convertible Preferred Stock
2011-06-06$1000.00/sh−75→ 2,987.5 total

Companies

ELITE PHARMACEUTICALS INC /NV/
Director, 10% Owner
$ELTP

Recent Filings

Address

C/O EPIC PHARMA, LLC 227-15 NORTH CONDUIT AVENUE

LAURELTON, NY, 11413-3134

View on SEC.gov